Search hospitals > Texas > Dallas
Metroplex Clinical Research Center
Claim this profileDallas, Texas 75231
Global Leader in Arthritis
Global Leader in Rheumatoid Arthritis
Conducts research for Juvenile Idiopathic Arthritis
Conducts research for Lupus
Conducts research for Osteoarthritis
97 reported clinical trials
2 medical researchers
Summary
Metroplex Clinical Research Center is a medical facility located in Dallas, Texas. This center is recognized for care of Arthritis, Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Lupus, Osteoarthritis and other specialties. Metroplex Clinical Research Center is involved with conducting 97 clinical trials across 50 conditions. There are 2 research doctors associated with this hospital, such as Roy Fleischmann and STANLEY COHEN.Area of expertise
1Arthritis
Global LeaderRheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
2Rheumatoid Arthritis
Global LeaderRheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
Top PIs
Roy FleischmannMetroplex Clinical Research Center2 years of reported clinical research
Studies Arthritis
Studies Juvenile Idiopathic Arthritis
8 reported clinical trials
14 drugs studied
STANLEY COHENMetroplex Clinical Research Center1 year of reported clinical research
Studies Rheumatoid Arthritis
Studies Arthritis
7 reported clinical trials
7 drugs studied
Clinical Trials running at Metroplex Clinical Research Center
Lupus
Arthritis
Psoriatic Arthritis
Juvenile Idiopathic Arthritis
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Cutaneous Lupus Erythematosus
Deucravacitinib
for Lupus
This trial is testing a new medication called deucravacitinib to see if it is safe and effective for people with moderate to severe lupus, a disease where the immune system attacks the body. The medication aims to reduce inflammation by targeting specific enzymes in the immune system.
Recruiting1 award Phase 3
Cenerimod
for Systemic Lupus Erythematosus
This trial is testing cenerimod, a medication aimed at reducing symptoms of Systemic Lupus Erythematosus (SLE) in adults with moderate to severe symptoms. Researchers want to see if cenerimod can help when added to existing treatments. The medication works by calming the overactive immune system, which may reduce inflammation and other symptoms.
Recruiting1 award Phase 32 criteria
Edecesertib
for Cutaneous Lupus Erythematosus
This trial is testing a new drug called edecesertib to see if it can help treat a skin condition known as Cutaneous Lupus Erythematosus (CLE). The study will look at how the drug affects the body, how the body processes it, and any side effects that occur. The goal is to find out if edecesertib is an effective treatment for people with CLE.
Recruiting0 awards Phase 26 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Metroplex Clinical Research Center?
Metroplex Clinical Research Center is a medical facility located in Dallas, Texas. This center is recognized for care of Arthritis, Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Lupus, Osteoarthritis and other specialties. Metroplex Clinical Research Center is involved with conducting 97 clinical trials across 50 conditions. There are 2 research doctors associated with this hospital, such as Roy Fleischmann and STANLEY COHEN.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.